Invention Grant
US08110370B2 IBC-1 (Invasive Breast Cancer-1), a putative oncogene amplified in breast cancer
有权
IBC-1（侵袭性乳腺癌1），乳腺癌中放大的推定癌基因
- Patent Title: IBC-1 (Invasive Breast Cancer-1), a putative oncogene amplified in breast cancer
- Patent Title (中): IBC-1（侵袭性乳腺癌1），乳腺癌中放大的推定癌基因
-
Application No.: US12573017Application Date: 2009-10-02
-
Publication No.: US08110370B2Publication Date: 2012-02-07
- Inventor: Kornelia Polyak , Dale Porter
- Applicant: Kornelia Polyak , Dale Porter
- Applicant Address: US MA Boston
- Assignee: Dana-Farber Cancer Institute, Inc.
- Current Assignee: Dana-Farber Cancer Institute, Inc.
- Current Assignee Address: US MA Boston
- Agency: Fish & Richardson P.C.
- Main IPC: C12Q1/68
- IPC: C12Q1/68 ; G01N33/567 ; G01N33/574 ; G01N33/48 ; G01N33/00 ; G01N1/00
Abstract:
This invention encompasses antibodies specific for IBC-1 (Invasive Breast Cancer-1), methods for diagnosis and prognosis of metastatic breast cancer and degenerative neural conditions, methods of identifying and manufacturing therapeutic compounds, and methods of treating patients with invasive and metastatic breast cancer or degenerative neural conditions.
Public/Granted literature
- US20100196891A1 IBC-1 (Invasive Breast Cancer-1), a Putative Oncogene Amplified in Breast Cancer Public/Granted day:2010-08-05
Information query
